Peptigroupe Inc Report issue

For profit Phase 1
Founded: Montreal Canada (2010)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2017
NCT04060043
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Peptigroupe Inc | Peptigroupe Inc.

Active Ingredients

Drugs in Phase 1 Trials (2)

goserelin (zoladex) (1 trial)

treamid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhage (Phase 1)

Metrorrhagia (Phase 1)

Prostatic Neoplasms (Phase 1)

Uterine Hemorrhage (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2